Acta Med. 2024, 67: 53-59

https://doi.org/10.14712/18059694.2024.20

Impact of Age on Predictive Capabilities of Ferritin, Ferritin-Hemoglobin Ratio, IL-6, and sIL-2R for COVID-19 Severity and Mortality

Oleksii Skakuna, Yaroslava Vandzhurab, Ihor Vandzhurab, Khrystyna Symchychc, Anton Symchychd

aClinic of St. Luka, Ivano-Frankivsk, Ukraine
bIvano-Frankivsk National Medical University, Department of Internal Medicine #2 and Nursing, Ivano-Frankivsk, Ukraine
cIvano-Frankivsk National Medical University, Department of Therapy, Family and Emergency Medicine Postgraduate Education, Ivano-Frankivsk, Ukraine
dIvano-Frankivsk National Medical University, Department of General and Vascular Surgery, Ivano-Frankivsk, Ukraine

Received May 2, 2024
Accepted August 15, 2024

References

1. Kneip T, Börsch-Supan A, Andersen-Ranberg K. Social, health and economic impact of the COVID-19 pandemic from a European perspective. Eur J Ageing. 2022 Nov 14; 19(4): 789–92. <https://doi.org/10.1007/s10433-022-00744-9> <PubMed>
2. WHO. WHO COVID-19 dashboard (Internet). World Health Organization. 2023. Available from: https://covid19.who.int/ (Accessed 15-Oct-2023).
3. Our World in Data. Mortality Risk of COVID-19 – Statistics and Research (Internet). Our World in Data. Available from: https://ourworldindata.org/mortality-risk-covid (Accessed 15-Oct-2023).
4. Xie Y, Choi T, Al-Aly Z. Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022–2023. JAMA. 2023; 329(19): 1697–9. <https://doi.org/10.1001/jama.2023.5348> <PubMed>
5. Wang H, Paulson KR, Pease SA, Watson S, Comfort H, Zheng P. COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet. 2022 Apr 16; 399(10334): 1513–36. <https://doi.org/10.1016/S0140-6736(21)02796-3> <PubMed>
6. Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory immune response and COVID-19: a double edged sword. Front Immunol. 2021; 12: 742941. <https://doi.org/10.3389/fimmu.2021.742941> <PubMed>
7. Khan A, Khan WM, Ayub M, Humayun M, Haroon M. Ferritin Is a Marker of Inflammation rather than Iron Deficiency in Overweight and Obese People. J Obes. 2016; 2016: 1937320.
8. DePalma RG, Hayes VW, O’Leary TJ. Optimal serum ferritin level range: iron status measure and inflammatory biomarker. Metallomics. 2021 Jun 11; 13(6): mfab030. <https://doi.org/10.1093/mtomcs/mfab030> <PubMed>
9. Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017 Nov 1; 29(9): 401–9. <https://doi.org/10.1093/intimm/dxx031> <PubMed>
10. Zhou Z, Yang D, Li C, Wu T, Shi R. Serum ferritin and the risk of short-term mortality in critically ill patients with chronic heart failure: a retrospective cohort study. Front Physiol. 2023 Jul 13; 14: 1148891. <https://doi.org/10.3389/fphys.2023.1148891> <PubMed>
11. Ahmed S, Ansar Ahmed Z, Siddiqui I, Haroon Rashid N, Mansoor M, Jafri L. Evaluation of serum ferritin for prediction of severity and mortality in COVID-19 – A cross sectional study. Ann Med Surg (Lond). 2021 Mar; 63: 102163.
12. Kurian SJ, Mathews SP, Paul A, et al. Association of serum ferritin with severity and clinical outcome in COVID-19 patients: An observational study in a tertiary healthcare facility. Clin Epidemiol Glob Health. 2023 May–Jun; 21: 101295. <https://doi.org/10.1016/j.cegh.2023.101295> <PubMed>
13. Mourji D, Abouelfath Z, Abassor T, et al. Association between Ferritin and COVID-19 Mortality in 1310 Moroccan Patients. Cross current international journal of medical and Biosciences. 2022 Jul 12; 4(3): 50–4. <https://doi.org/10.36344/ccijmb.2022.v04i03.001>
14. Feld J, Tremblay D, Thibaud S, Kessler A, Naymagon L. Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis. Int J Lab Hematol. 2020 Dec; 42(6): 773–9. <https://doi.org/10.1111/ijlh.13309> <PubMed>
15. Chicamy YA, Safitri A, Nindrea RD. Serum Ferritin Levels for the Prediction of Mortality among COVID-19 Patients in an Indonesia’s National Referral Hospital. Open Access Maced J Med Sci. 2022 May 5; 10(B): 1056–61. <https://doi.org/10.3889/oamjms.2022.8777>
16. Raman N, Kv P, Ashta KK, Vardhan V, et al. Ferritin and Hemoglobin as Predictors of Fatal Outcome in COVID-19: Two Sides of the Same Coin. J Assoc Physicians India. 2021 Aug; 69(8): 11–12.
17. Aygun H, Eraybar S. Can ferritin/lymphocyte percentage ratio, a new indicator, predict the clinical course of COVID-19 cases? Bratisl Lek Listy. 2022; 123(6): 395–400.
18. Yurt NS, Ocak M. Ferritin/lymphocyte percentage ratio to predict the severity and mortality of COVID-19. Malawi Med J. 2023 Oct 11; 35(3): 183–9. <https://doi.org/10.4314/mmj.v35i3.8> <PubMed>
19. Taşkin Ö, Yilmaz A, Soylu VG, Demir U, Çatan IF. Ferritin/albumin ratio could be a new indicator of COVID-19 disease mortality. J Infect Dev Ctries. 2023 Jan 31; 17(1): 37–42. <https://doi.org/10.3855/jidc.17409>
20. Dahan S, Segal G, Katz I, et al. Ferritin as a Marker of Severity in COVID-19 Patients: A Fatal Correlation. Isr Med Assoc J. 2020 Aug; 22(8): 494–500.
21. Para O, Caruso L, Pestelli G, et al. Ferritin as prognostic marker in COVID-19: the FerVid study. Postgrad Med. 2022 Jan; 134(1): 58–63. <https://doi.org/10.1080/00325481.2021.1990091> <PubMed>
22. Anai M, Akaike K, Iwagoe H, et al. Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia. Respir Investig. 2021 Mar; 59(2): 187–93. <https://doi.org/10.1016/j.resinv.2020.10.009> <PubMed>
23. Xu Y, Yang H, Wang J, et al. Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China. Int J Gen Med. 2021 Jun 24; 14: 2785–97. <https://doi.org/10.2147/IJGM.S312521> <PubMed>
24. Zerbato V, Sanson G, De Luca M, et al. The Impact of Serum Albumin Levels on COVID-19 Mortality. Infect Dis Rep. 2022 Apr 20; 14(3): 278–86. <https://doi.org/10.3390/idr14030034> <PubMed>
25. Li Y, Yang T, Wang S, et al. The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative. Bosn J Basic Med Sci. 2021 Apr 1; 21(2): 235–41.
26. Ziadi A, Hachimi A, Admou B, et al. Lymphopenia in critically ill COVID-19 patients: A predictor factor of severity and mortality. Int J Lab Hematol. 2021 Feb; 43(1): e38–e40. <https://doi.org/10.1111/ijlh.13351> <PubMed>
27. Liu J, Li H, Luo M, et al. Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study. PLoS One. 2020 Nov 18; 15(11): e0241659. <https://doi.org/10.1371/journal.pone.0241659> <PubMed>
28. Hadi JM, Mohammad HM, Ahmed AY, et al. Investigation of Serum Ferritin for the Prediction of COVID-19 Severity and Mortality: A Cross-Sectional Study. Cureus. 2022 Nov 28; 14(11): e31982.
29. Jang HJ, Leem AY, Chung KS, et al. Soluble IL-2R Levels Predict in-Hospital Mortality in COVID-19 Patients with Respiratory Failure. J Clin Med. 2021 Sep 18; 10(18): 4242. <https://doi.org/10.3390/jcm10184242> <PubMed>
30. Nikkhoo B, Mohammadi M, Hasani S, et al. Elevated interleukin (IL)-6 as a predictor of disease severity among Covid-19 patients: a prospective cohort study. BMC Infect Dis. 2023 May 9; 23(1): 311. <https://doi.org/10.1186/s12879-023-08294-w> <PubMed>
31. Luporini RL, Rodolpho JMA, Kubota LT, et al. IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19. Cytokine. 2021 Jul; 143: 155507. <https://doi.org/10.1016/j.cyto.2021.155507> <PubMed>
32. Motojima S, Hirata A, Fukuda T, Makino S. High serum soluble interleukin-2 receptor concentrations in elderly individuals and smokers. Arerugi. 1993 Nov; 42(11): 1715–20.
33. Ministerstvo Okhorony Zdorovia Ukrainy. Derzhavnyi Ekspertnyi Tsentr (Internet). Protokol “Nadannia medychnoi dopomohy dlia likuvannia koronavirusnoi khvoroby (COVID-19)” (cited 17-Oct-2023). Available from: https://www.dec.gov.ua/wp-content/uploads/2023/05/protokol-covid2023.pdf. Ukrainian.
34. Cao P, Wu Y, Wu S, et al. Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia. Biomarkers. 2021 May; 26(3): 207–12. <https://doi.org/10.1080/1354750X.2020.1861098> <PubMed>
35. Deng F, Zhang L, Lyu L, et al. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin (Engl Ed). 2021 Apr 9; 156(7): 324–31.
36. Shakaroun DA, Lazar MH, Horowitz JC, Jennings JH. Serum Ferritin as a Predictor of Outcomes in Hospitalized Patients with Covid-19 Pneumonia. J Intensive Care Med. 2023 Jan; 38(1): 21–6. <https://doi.org/10.1177/08850666221113252> <PubMed>
37. Aykal G, Esen H, Seyman D, Çalışkan T. Could IL-6 predict the clinical severity of COVID-19? Turk J Biochem. 2021 Oct 1; 46(5): 499–507. <https://doi.org/10.1515/tjb-2021-0020>
38. Jamoussi A, Messaoud L, Jarraya F, et al. Interleukin-6 prediction of mortality in critically ill COVID19 patients: A prospective observational cohort study. PLoS One. 2023 Mar 1; 18(3): e0279935. <https://doi.org/10.1371/journal.pone.0279935> <PubMed>
39. Arnold DT, Attwood M, Barratt S, et al. Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study. Emerg Med J. 2021 Jul; 38(7): 543–8. <https://doi.org/10.1136/emermed-2020-210380>
40. Wyczalkowska-Tomasik A, Czarkowska-Paczek B, Zielenkiewicz M, Paczek L. Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges. Arch Immunol Ther Exp (Warsz). 2016 Jun; 64(3): 249–54. <https://doi.org/10.1007/s00005-015-0357-7> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive